At the time of clinical onset, T1D patients have lost nearly 80% or more of their insulin-secreting β cells to inflammation, immune-mediated ECM degradation, β cell stress, and other mechanisms (Figure 2) (239). Here, INS is linked to type 1 diabetes mellitus.